返回医生团队

陈新淦 Dr. Xingan Chen

副主任医师 / 兼职副教授

专家风采 专家风采

上海国际医学中心中医科主诊专家,副主任医师 上海国际医学中心中医科主诊专家,副主任医师 上海中医药大学 · 兼职副教授 上海中医药大学 · 兼职副教授 中医临床 40 余年 · 肿瘤围术期中医干预 中医临床 40 余年 · 肿瘤围术期中医干预
重点方向 重点方向
肿瘤围术期与术后康复期中医药治疗,浆细胞性乳腺炎病灶控制与复发预防 肿瘤围术期与术后康复期中医药治疗,浆细胞性乳腺炎病灶控制与复发预防
学术任职 学术任职
上海市中医药学会综合医院中医发展分会委员、上海市中西医结合学会心身医学专委会委员、上海市中医药学会中青年分会委员 上海市中医药学会综合医院中医发展分会委员、上海市中西医结合学会心身医学专委会委员、上海市中医药学会中青年分会委员
擅长病种 擅长病种
乳腺增生、乳腺结节、积乳症等良性疾病中医药干预;化疗/放疗/内分泌期减毒增效与免疫支持 乳腺增生、乳腺结节、积乳症等良性疾病中医药干预;化疗/放疗/内分泌期减毒增效与免疫支持
陈新淦医生照片 / Dr. Xingan Chen portrait
Photo coming soon

陈新淦,上海国际医学中心中医科主诊专家,副主任医师,上海中医药大学兼职副教授。

  • 学术任职:上海中医药大学兼职副教授,上海市中医药学会综合医院中医发展分会委员,上海市中西医结合学会心身医学专委会委员,上海市中医药学会中青年分会委员。
  • 专业履历:发表专业学术论文 20 多篇。历任老中医“名医堂”常务副堂长、医疗副院长、医务处长、针伤科主任等职。
  • 临床经验:从事中医临床工作四十余年,擅长中医辨证论治,尤其在肿瘤围术期及术后康复期中医药治疗方面积累了丰富临床经验。
  • 特色优势:对浆细胞性乳腺炎在病灶控制逆转、促进切口愈合、防止复发方面形成了独特验方和疗效;在乳腺增生症、乳腺结节、积乳症等良性疾病中医药干预方面疗效显著。
  • 综合干预:针对肿瘤患者化疗期、放疗期、内分泌治疗期,运用中医药起到排毒增效、减少不良反应、改善睡眠障碍、提高免疫力的作用。

教育背景: 浙江中医药大学医学院(原浙江中医学院)

Dr. Xingan Chen is an Attending Specialist and Associate Chief Physician in the TCM Department at Shanghai International Medical Center, and an Adjunct Associate Professor at Shanghai University of Traditional Chinese Medicine.

  • Academic appointments: Adjunct Associate Professor at Shanghai University of Traditional Chinese Medicine; Committee Member of the TCM Development Branch for General Hospitals (Shanghai Society of Traditional Chinese Medicine); Committee Member of the Psychosomatic Medicine Committee (Shanghai Society of Integrated Chinese-Western Medicine); and Committee Member of the Young and Middle-aged Branch (Shanghai Society of Traditional Chinese Medicine).
  • Professional profile: Author of more than 20 academic papers. Formerly served as Executive Deputy Director of a veteran-physician clinic (\"Mingyi Hall\"), Vice President for Medical Affairs, Director of Medical Affairs, and Head of Acupuncture and Trauma Department.
  • Clinical experience: More than 40 years of clinical TCM practice, with strong expertise in syndrome differentiation and treatment, especially in perioperative and postoperative TCM management for oncology patients.
  • Signature strengths: Developed effective clinical formulas and treatment strategies for plasma cell mastitis, including lesion control/reversal, improved incision healing, and recurrence prevention. Also experienced in TCM intervention for benign breast diseases such as hyperplasia, breast nodules, and milk stasis.
  • Supportive oncology care: During chemotherapy, radiotherapy, and endocrine therapy, TCM interventions are used to support detoxification and efficacy enhancement, reduce adverse effects, improve sleep disorders, and strengthen immune function.

Education: Medical School of Zhejiang Chinese Medical University (formerly Zhejiang College of Traditional Chinese Medicine)